Skip to main content
CHOLESTEROL, TRIGLYCERIDES & STATINS

The Statin Next to Your Diabetes Medicines: What to Expect

Three honest questions come up about statins in diabetes — why this tablet, does it raise blood sugar, and what about the muscle aches. All three have real answers.

7 min read
Close-up photograph of a blister pack of small round pink tablets
Photo via jarmoluk / Pixabay (opens in a new tab)

Sooner or later, most people managing Type 2 diabetes leave a clinic with a statin added to the prescription — atorvastatin or rosuvastatin, usually — sitting quietly next to the metformin. It tends to arrive with very little explanation, and it raises three reasonable questions that rarely get answered in a five-minute visit.

Why this tablet, when my cholesterol report didn't look that bad? Doesn't it raise blood sugar — which seems like exactly the wrong thing for me? And isn't this the medicine everyone says causes muscle pain? None of the three is a silly question, and none of them has a hand-waving answer.

What the tablet is actually doing

Most of the cholesterol in your blood didn't come from your plate — your liver manufactures it, and it does most of that work while you sleep. A statin blocks the enzyme the liver uses to build cholesterol, so less is produced and the liver pulls more LDL out of your bloodstream to make up the difference. That's the whole mechanism, and it's also why the timing instructions differ between statins, which we'll come back to.

As for why it was prescribed when your LDL looked acceptable: in diabetes, a statin is prescribed for your overall cardiovascular risk rather than for a number crossing a line on the report. That reasoning, and the LDL targets that go with it, are covered in our guide to cholesterol levels for a diabetic patient — the rest of this article is about living with the tablet itself.

Yes, statins nudge blood sugar up — here is how much

This one deserves a straight answer rather than reassurance, because the effect is real and it has been measured carefully. In 2024 the Cholesterol Treatment Trialists' Collaboration pooled the individual data (opens in a new tab) from 19 double-blind trials covering 123,940 people, nearly a fifth of whom already had Type 2 diabetes.

Among people who did not have diabetes at the start, statins raised average HbA1c by 0.06% on a low or moderate dose and by 0.08% on a high dose, with average glucose rising by 0.04 mmol/L. New diabetes diagnoses went up too — by 10% in relative terms on lower doses and 36% on high-intensity doses.

That 36% sounds alarming until you look at who it happened to. About 62% of those extra diagnoses occurred in people who were already in the top quarter of blood sugar readings before the trial began — people sitting just under the diagnostic threshold. The statin didn't give them diabetes so much as move them over a line they were already standing on.

If you already have diabetes, the relevant finding is a different one: statins increased measures of worsening blood sugar control by about 10% on lower doses and 24% on high-intensity doses. That is a count of how often a worsening marker was recorded, not a jump in your HbA1c — the measured glycaemic shift, in the participants who did not have diabetes, was the 0.06-0.08% above. It is the kind of change that shows up across 124,000 people and disappears in a single person’s life next to a skipped walk or a wedding dinner.

Note: The trial authors' own conclusion

The CTT researchers were direct about the trade-off: the diabetes-related risks arising from these small increases in blood sugar are greatly outweighed by the benefit of statins in preventing heart attacks and strokes. A slightly higher HbA1c is a manageable problem. A heart attack is not.

What this does mean is that if your HbA1c creeps up shortly after starting a statin, it is worth mentioning to your doctor as context — not as a reason to stop the tablet, and not as evidence that your own efforts have failed.

The muscle aches: real, common, and more complicated than expected

Muscle pain is the single most common reason people quietly abandon a statin. It is listed as a side effect by the NHS (opens in a new tab) alongside headache, tiredness, nausea and digestive symptoms, so nobody is imagining things. But a trial called SAMSON asked a sharper question than "do statins cause aches" — it asked whether the statin, or the tablet, was responsible.

Sixty people who had already given up on statins because of side effects (opens in a new tab) spent a year taking, in random order, four months of atorvastatin, four months of identical-looking placebo, and four months of nothing at all, rating their symptoms on a phone every day. They genuinely felt worse during tablet months than during empty months. But the placebo months were almost as bad as the statin months — 90% of the symptom burden appeared on the dummy tablets too.

The researchers' reading of this was not that patients were exaggerating. It was that the symptoms are entirely real and are mostly caused by the act of taking a tablet rather than by the drug inside it. After being shown their own charts, about half of the participants went back onto a statin successfully — people who had been written off as statin-intolerant.

The practical takeaway isn't "push through it." It's that muscle aches are a conversation with your doctor, not a private decision. The NHS route is to say something rather than stop: a different statin, a lower dose, or a supervised break to see whether the symptoms actually track the tablet are all normal, unremarkable next steps. Some people genuinely cannot tolerate any statin, and that is a real finding worth establishing properly — but it should be established, not assumed.

Warning: Muscle symptoms that need a call today, not at your next visit

Contact your doctor promptly if muscle pain, tenderness or weakness comes with fever, flu-like symptoms or unusual exhaustion, or if you notice dark-coloured urine, yellowing of the skin or eyes, loss of appetite or pain in the upper right side of your abdomen. These are the uncommon reactions that need checking rather than waiting out.

When to take it, and what not to take it with

The timing instruction depends on which statin you were given, because they clear from the body at different speeds. MedlinePlus (opens in a new tab) instructs simvastatin tablets to be taken once a day in the evening, so the drug is present while the liver is doing its overnight work. Atorvastatin (opens in a new tab), which lingers far longer, simply needs to be taken at around the same time every day, with or without food. If you are on something else, follow the instruction printed on your own box — the point is that consistency is doing most of the work.

Interactions matter more than people expect. The NHS lists grapefruit (chakotra) and its juice as something that can increase statin side effects, along with some blood pressure medicines, antifungals, certain antibiotics, HIV medicines and warfarin. This is worth remembering in a country where antibiotics are often handed over the pharmacy counter without a prescription: whoever gives you a new medicine should be told you are on a statin, even if they didn't ask.

One situation where a statin should be stopped

Statins are not safe in pregnancy. MedlinePlus is unambiguous: if you become pregnant while taking atorvastatin, stop it and call your doctor immediately, and do not breastfeed while taking it. The NHS similarly advises against statins in pregnancy and for people of childbearing age who are not using contraception.

For a woman with diabetes who is planning a pregnancy, this is something to raise with your doctor before conceiving rather than after — pregnancy with diabetes involves rearranging several medicines, and the statin is one of them. This is the one situation in this article where stopping is the correct answer, and it still goes through your doctor.

Log the statin the way you log everything else

If you started a statin recently, note the date and the dose in Diatic alongside your readings. If your HbA1c shifts, or if aches start, you'll be able to show your doctor when it began instead of trying to remember — which is the difference between a useful conversation and a guess.

Start logging (opens Diatic on Google Play in a new tab)

Frequently asked questions

Is a statin something I take forever?

Usually, yes — the NHS describes statins as a long-term treatment, and notes that cholesterol levels are affected again if you stop. It isn't a course you finish, like an antibiotic. Your liver goes back to producing cholesterol at its old rate once the tablet stops, so the protection lasts as long as the treatment does. That said, doses do get reviewed and adjusted over the years, so it isn't set in stone either.

My doctor switched me from one statin to another. Did the first one fail?

Not necessarily, and it usually isn't a sign that something went wrong. Switching between statins, or adjusting the dose, is one of the standard responses the NHS describes for side effects — and doctors also switch to reach a stronger LDL reduction, or simply because of what is available and affordable locally. It's routine adjustment rather than a setback.

Should I still take my statin while fasting in Ramadan?

A statin doesn't affect blood sugar the way diabetes medicines do, so the fasting-related concerns are different — it's mainly a question of when the dose fits. If you take simvastatin, its evening timing lines up naturally with the period after iftar. If you take atorvastatin, what matters is picking a consistent time within the non-fasting hours and keeping to it for the month. Confirm the plan with your doctor before Ramadan starts rather than working it out on the first night.

Sources

  1. American Diabetes Association (ADA) — Standards of Care in Diabetes 2025, Section 10: Cardiovascular Disease and Risk Management (opens in a new tab)
  2. Endotext (NCBI Bookshelf, NIH) — Dyslipidemia in Patients with Diabetes (opens in a new tab)
  3. MedlinePlus (U.S. National Library of Medicine) — Cholesterol testing and results (opens in a new tab)
  4. Pakistan Journal of Medical Sciences — Frequency and pattern of dyslipidemia and its association with other risk factors among Type-2 Diabetics (opens in a new tab)
  5. Cholesterol Treatment Trialists' (CTT) Collaboration — Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia: an individual participant data meta-analysis (The Lancet Diabetes & Endocrinology, 2024) (opens in a new tab)
  6. NHS (UK) — Statins (opens in a new tab)
  7. SAMSON trial — N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects (New England Journal of Medicine, 2020) (opens in a new tab)
  8. MedlinePlus (U.S. National Library of Medicine) — Atorvastatin (opens in a new tab)
  9. MedlinePlus (U.S. National Library of Medicine) — Simvastatin (opens in a new tab)
  10. StatPearls (NCBI Bookshelf, NIH) — Dietary Therapy for LDL Cholesterol Reduction: Evidence-Based Patterns for Cardiovascular Risk Management (opens in a new tab)
  11. StatPearls (NCBI Bookshelf, NIH) — Statin Medications (opens in a new tab)
  12. Jovanovski et al. — Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials (The American Journal of Clinical Nutrition, 2018) (opens in a new tab)
  13. The Endocrine Society — Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (Journal of Clinical Endocrinology & Metabolism, 2012) (opens in a new tab)
  14. Journal of Clinical Lipidology (2025) — Trends and prevalence of severe hypertriglyceridemia in Pakistan: A 5-year analysis (2019–2023) (opens in a new tab)
  15. Cureus (2017) — Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus (opens in a new tab)
  16. American Diabetes Association (ADA) — Standards of Care in Diabetes 2026, Section 10: Cardiovascular Disease and Risk Management (opens in a new tab)
  17. Drug Design, Development and Therapy (2019) — Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets (opens in a new tab)
  18. Diabetes & Metabolism Journal — Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial (opens in a new tab)
  19. American Diabetes Association (ADA) — Standards of Care in Diabetes 2026, Section 3: Prevention or Delay of Diabetes and Associated Comorbidities (opens in a new tab)
  20. Pan African Medical Journal (2013) — Prevalence of Vitamin B12 deficiency in patients of type 2 diabetes mellitus on metformin: a case control study from Pakistan (opens in a new tab)
  21. MedlinePlus (U.S. National Library of Medicine) — Metformin (opens in a new tab)
  22. NHS (UK) — Metformin (opens in a new tab)
  23. World Journal of Diabetes — Metformin-associated lactic acidosis: A mini review of pathophysiology, diagnosis and management in critically ill patients (opens in a new tab)

Related reading